Torrent Pharma Vista Division Product List
Torrent Pharmaceuticals Ltd. (Vista) brand List that includes tablets, capsules, syrups, etc. Brands listed with corresponding Generic name and price details. Product List Aceclofenac. Torrent Pharmaceuticals Limited manufactures, markets and/or distributes more than 42 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
• Baddi Plant received OHAS Audit certification; facility approved by the regulatory authority of Uganda • An advanced facility for Stability Studies set up at Indrad Plant • Entered into the therapeutic area of Gynaecology • Commenced commercial operations of Laboratories Torrent S.A. De C.V., Mexico • Started construction of Dahej manufacturing facility • Commissioned a subsidiary in United Kingdom and Romania • Torrent Research Center develops Long Acting Injectables technology • Foray into oncology segment •. • New manufacturing unit at Baddi, Himachal Pradesh, set up to cater to domestic formulations market. • Torrent Pharma signed an agreement with Novo Nordisk India to establish a new, dedicated formulation and packaging facility for Insulin, exclusively for Novo Nordisk. • Acquired Heumann Pharma GmbH & Co Generica KG, a Pfizer group company, in Germany.
• Two new marketing divisions- AXON and NEURON set up to cater to neuropsychiatry segment. • Entered into a research collaboration with AstraZeneca for developing novel anti-hypertensive drug. • Torrent Pharma's QC department at Chhatral manufacturing plant accredited with ISO/IEC- 17025 by NABL •. • Discovered and patented AGE (Advanced Glycosylation End-products) molecule. • Torrent Pharma's Indrad Plant receives ISO and OHSAS • Torrent's R&D Centre received ISO/IEC for its facilities by National Accreditation Board for Testing and Calibration Laboratories (NABL). • Addition of a new marketing division, MIND • Dual Retard Inlay Technology, Compact Tablet Technology, Gastro Retentive System and Multiparticulate / Matrix Based SR / Modified Release Formulations developed indigenously by Torrent Research Center (2002) • Torrent Pharma bagged the Gold Trophy for IDMA Quality Excellence Award 2003 for both Formulations and API manufacturing facilities • Brazilian Sanitary Surveillance Agency accredited Torrent's R&D Centre with ANVISA, authorizing it to conduct Bioequivalance Studies.
Beta 2 phosphor. - Various stability and performance improvements.
Torrent Pharma, the flagship Company of Torrent Group, with a turnover of Rs. 6080 Cr is one of the leading Pharma companies in the Country. We are the pioneers in initiating the concept of niche marketing in India and today we rank amongst the leaders in the therapeutic segments of Cardiovascular (CV) and Central Nervous System (CNS).We also have significant presence in Gastro-Intestinal, Diabetology, Anti-Infective and Pain Management segments. Torrent Pharma has crossed many geographical boundaries with presence in more than 40 countries. The Company is ranked first amongst Indian Companies for having largest market share in Brazil and Germany.